C Collin

Summary

Affiliation: Royal Berkshire Hospital
Country: UK

Publications

  1. ncbi Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis
    C Collin
    Department of Neurorehabilitation, Royal Berkshire and Battle NHS Trust, Reading, UK
    Eur J Neurol 14:290-6. 2007
  2. ncbi Multivariate analysis of the Fugl-Meyer outcome measures assessing the effectiveness of GENTLE/S robot-mediated stroke therapy
    Farshid Amirabdollahian
    Think Lab, The University of Salford, Maxwell Building, Salford, M5 4WT, UK
    J Neuroeng Rehabil 4:4. 2007
  3. ncbi A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis
    C Collin
    Royal Berkshire and Battle Hospitals NHS Trust, London Road, Reading, Berkshire RG1 5AN, UK
    Neurol Res 32:451-9. 2010

Collaborators

  • W Notcutt
  • Farshid Amirabdollahian
  • Garth Johnson
  • Rui Loureiro
  • Elizabeth Gradwell
  • William Harwin

Detail Information

Publications3

  1. ncbi Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis
    C Collin
    Department of Neurorehabilitation, Royal Berkshire and Battle NHS Trust, Reading, UK
    Eur J Neurol 14:290-6. 2007
    ..014). Eight withdrawals were attributed to adverse events (AEs); six were on active preparation and two on placebo. We conclude that this CBM may represent a useful new agent for treatment of the symptomatic relief of spasticity in MS...
  2. ncbi Multivariate analysis of the Fugl-Meyer outcome measures assessing the effectiveness of GENTLE/S robot-mediated stroke therapy
    Farshid Amirabdollahian
    Think Lab, The University of Salford, Maxwell Building, Salford, M5 4WT, UK
    J Neuroeng Rehabil 4:4. 2007
    ..In this paper we present the results obtained from trialling the GENTLE/S neurorehabilitation system assessed using the upper limb section of the Fugl-Meyer (FM) outcome measure...
  3. ncbi A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis
    C Collin
    Royal Berkshire and Battle Hospitals NHS Trust, London Road, Reading, Berkshire RG1 5AN, UK
    Neurol Res 32:451-9. 2010
    ..Muscle spasticity is common in multiple sclerosis (MS), occurring in more than 60% of patients...